Restore Biodiagnostics Receives NIH Grant To Develop Innovative Stress Hormone Test

Restore Biodiagnostics Receives NIH Grant To Develop Innovative Stress Hormone Test
Restore Biodiagnostics, a division of national compounding phramacy Restore Health, has received an NIH grant to develop an innovative test to determine an individual's stress level measuring the stress hormone Cortisol.

Madison, WI (PRWEB) March 16, 2012

Underscoring their commitment to innovative research in the field of diagnostics and personal hormone health, Restore Biodiagnostics, a Restore Health company specializing in hormone testing and other advanced diagnostics, has received a NIH grant to develop a rapid point of care test to determine an individual's stress level using a single saliva specimen in 15 minutes or less. The test will semi-quantitavely measure the stress hormone Cortisol.

Funding for the $325,000 project is provided by the National Institutes of Health's National Center for Complementary and Alternative Medicine. The technology under development is based on an immunochromatographic test platform delivering real time immediate results in laboratory or field settings where standard laboratory equipment might not be available.

Phase one of the project will validate the technology against standardized enzyme linked immunosorbent assays (ELISA) for the measurement of stress levels in Cortisol. Phase two of the project will demonstrate the technological effectiveness in laboratory settings under both stressful and non stressful situations. This underpinning will also aid in the development and refinement of protocols with stress research in human clinical trials.

Restore Biodiagnostics is collaborating with Oasis Diagnostics (Vancouver, WA) and the University of New Orleans with the validation of the technology.

About Restore Biodiagnostics
Restore Biodiagnostics specializes in salivary and urinary biomarker testing for academic, clinical and industrial applications and is a division of Restore Health. America's leader in personalized healthcare since 1982, Restore Health specializes in the formulation of commercially unavailable, custom medications using only the highest quality ingredients, state-of-the-art technology, and the industry's highest standards of purity and quality control.

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.